Market Analysis — JERSEY CITY MEDICAL CENTER
NJ market | 4 hospitals | HHI: 3,922 (Concentrated)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
4
Hospitals in Market
661
Total Beds
$0.8B
Market Revenue
Concentrated
HHI: 3,922
Narrow
Moat Rating (7/10)
#1
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantagestrong
Switching Costshigh
Market Share55.1%
Top 3 Concentration96.6%
Network Density0.61
Margin vs Market-5.5%
Bed Util vs Market+0.4%
What This Means
This hospital has a narrow moat — narrow moat — some competitive advantages, but vulnerable to new entrants. The NJ market is highly concentrated — few dominant players, potential antitrust concerns (HHI: 3,922).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full NJ market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| PALISADES MEDICAL CENTER | 186 | $191M | 23.0% | 28.1% |
| HUDSON REGIONAL HOSPITAL | 102 | $153M | 18.4% | 15.4% |
| MEADOWVIEW PSYCHIATRIC HOSPITAL | 84 | $28M | 3.4% | 12.7% |
Regional Payer Mix
■ Medicare 17%■ Medicaid 4%■ Commercial 79%